Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07064187Phase 4Completed
A Phase 4 trial of cationorm in Ocular discomfort. Started Jun 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07064187.